Carregant...
Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
The risk of cancer increases after transplantation. However, the consensus on immunosuppression (IS) adjustment after diagnosis of malignancy is lacking. Our study aims to assess the impact of IS adjustment on mortality of post-kidney transplant patients and allograft outcomes. We retrospectively re...
Guardat en:
| Publicat a: | J Clin Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6947374/ https://ncbi.nlm.nih.gov/pubmed/31835895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8122189 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|